Literature DB >> 6983881

Translation of interleukin 2 mRNA from human peripheral blood leukocytes in Xenopus oocytes.

S Hinuma, H Onda, K Naruo, Y Ichimori, M Koyama, K Tsukamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6983881     DOI： 10.1016/0006-291x(82)91729-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  17 in total

1.  Correlation of eosinophilia with clinical response in patients with advanced carcinoma treated with low-dose recombinant interleukin-2 and mitomycin C.

Authors:  S Arinaga; N Karimine; K Takamuku; S Nanbara; H Inoue; R Abe; D Watanabe; H Matsuoka; H Ueo; T Akiyoshi
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  Detection and characterization of anti-tumour effector cells in Meth-A-bearing mice treated with recombinant human interleukin 2.

Authors:  K I Naruo; S Hinuma; O Shiho; T Houkan; K Ootsu; K Tsukamoto
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

3.  The effect of recombinant interleukin 2 in combination with mitomycin C on advanced cancer.

Authors:  T Akiyoshi; S Arinaga; S Nanbara; N Karimine; H Inoue; K Takamuku; R Abe; D Watanabe; M Nagamatsu; H Matsuoka
Journal:  Jpn J Surg       Date:  1990-05

4.  Effects of recombinant interleukin 2 on immunological effector cells of the peripheral blood in patients with HBe antigen-positive chronic hepatitis.

Authors:  Y Mizoguchi; T Shin; Y Sakagami; S Seki; T Kuroki; K Kobayashi; S Yamamoto; S Morisawa
Journal:  Gastroenterol Jpn       Date:  1988-04

5.  Interferon gamma but not tumor necrosis factor alpha decreases susceptibility of human renal cell cancer cell lines to lymphokine-activated killer cells.

Authors:  Y Tomita; H Watanabe; H Kobayashi; T Nishiyama; S Tsuji; M Fujiwara; S Sato
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

6.  Effect of recombinant human interleukin-2 on the course of experimental chronic respiratory tract infection caused by Klebsiella pneumoniae in mice.

Authors:  Y Iizawa; T Nishi; M Kondo; K Tsuchiya; A Imada
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

7.  Cytotoxic cell function and phenotypic analysis of peripheral blood mononuclear cells in cancer patients treated with low-dose interleukin-2 and mitomycin C.

Authors:  S Arinaga; N Karimine; M Adachi; H Inoue; S Nanbara; T Asoh; H Ueo; T Akiyoshi
Journal:  Cancer Immunol Immunother       Date:  1993-09       Impact factor: 6.968

8.  Suppression of pulmonary tumour metastasis in mice by recombinant human interleukin-2: role of asialo GM1-positive cells.

Authors:  S Hinuma; K Naruo; K Ootsu; T Houkan; O Shiho; K Tsukamoto
Journal:  Immunology       Date:  1987-02       Impact factor: 7.397

9.  Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.

Authors:  S Hinuma; K Naruo; O Shiho; K Tsukamoto
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

10.  Tumor cytotoxicity of human monocyte membrane-bound interleukin-1 alpha induced by synergistic actions of interferon-gamma and synthetic acyltripeptide, FK-565.

Authors:  N Inamura; S Sone; A Okubo; E Kunishige; M Nakanishi; T Ogura
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.